Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the RX Herculink Elite® Renal Stent System for the treatment of renal artery stenosis (narrowing of the main arteries supplying blood to the kidneys) in patients with uncontrolled hypertension...
UroToday.com - Oncocytoma is a benign tumor originating from the distal tubule. Despite the benign nature of this tumor, it is resected in the vast majority of cases. The issue of pre-nephrectomy renal biopsy as a way to differentiate between benign and malignant renal tumors was addressed in...
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is...
UroToday.com - The availability of novel and promising targeted therapies for the treatment of patients with metastatic renal cell carcinoma (RCC), such as bevacizumab plus interferon and sunitinib, has meant important increases in options for patients and physicians treating this deadly...
UroToday.com - The Bosniak IIF cyst classification category was introduced to assist with mildly complex renal cystic lesions that were likely benign but required serial imaging to affirm stability. This allows the most concerning category Bosniak II lesions to be identified and upgraded...